Dow (DOW) Inks PCR Supply Deal With Avangard Innovative
Zacks Investment Research | Jan 15, 2020 09:23PM ET
Dow Inc. (NYSE:DOW) has inked a deal with Avangard Innovative LP, a waste-optimization specialist based in Houston. Per the exclusive agreement, Avangard Innovative will supply post-consumer resin (“PCR”) plastic film pellets to Dow.
Notably, PCR plastic film pellets will be a significant addition to Dow’s plastic circularity portfolio, which is consistent with its objective of advancing the plastics circular economy and reducing waste in the environment.
Later this year, Dow's first-ever PCR-based innovations will be offered to customers in North America, who demand stronger sustainability profiles in targeted applications such as shrink wrap, liners and protective packaging, among others.
Initially, Dow will use Avangard Innovative’s PCR to manufacture linear low-density polyethylene (LLDPE) and low-density polyethylene (LDPE) products.
Per Dow, the partnership blends waste collection and sortation technology from Avangard Innovative with Dow's materials science expertise, application expertise and operational scale to offer consistent processing, and reliable supply of PCR-based LLDPE and LDPE to its customers across North America.
Notably, Dow and Avangard Innovative are working to ensure that the value of plastics is not lost after only one material use.
Further, the partnership with Avangard Innovative is expected to put forth new solutions that will preserve the value of used plastics. Notably, this will help Dow and its customers fulfill their sustainability goals, thereby advancing toward a circular economy for plastics.
Dow’s shares have gained 9.3% over the past three months compared with 4.8% growth recorded by the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.